JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
ALI HEALTH
00241
BEKE-W
02423
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -308.47%-14.35M | ---- | -20.93%6.88M | ---- | -40.64%8.71M | ---- | 138.22%14.67M | ---- | -78.42%6.16M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -104.00%-51K | ---- | 69.51%-25K | ---- | -34.43%-82K | ---- | 16.44%-61K | ---- | -65.91%-73K |
Impairment and provisions: | ---- | --4.62M | ---- | ---- | ---- | ---- | ---- | -79.17%271K | ---- | 99.54%1.3M |
-Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -79.17%271K | ---- | 99.54%1.3M |
-Impairment of trade receivables (reversal) | ---- | --716K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other impairments and provisions | ---- | --3.91M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | -290.91%-215K | ---- | ---55K | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | -290.91%-215K | ---- | ---55K | ---- | ---- |
Depreciation and amortization: | ---- | 14.17%4.98M | ---- | 43.56%4.36M | ---- | -7.49%3.04M | ---- | -2.73%3.28M | ---- | 3.88%3.38M |
-Depreciation | ---- | 14.02%3.78M | ---- | 9.19%3.32M | ---- | -7.49%3.04M | ---- | -2.73%3.28M | ---- | 3.88%3.38M |
-Other depreciation and amortization | ---- | 14.66%1.2M | ---- | --1.04M | ---- | ---- | ---- | ---- | ---- | ---- |
Financial expense | ---- | 46.06%1.04M | ---- | 91.37%710K | ---- | -36.25%371K | ---- | -49.35%582K | ---- | 6.09%1.15M |
Unrealized exchange loss (gain) | ---- | -23.42%448K | ---- | --585K | ---- | ---- | ---- | ---- | ---- | ---- |
Special items | ---- | 113.06%161K | ---- | -316.32%-1.23M | ---- | 116.22%570K | ---- | -117,266.67%-3.52M | ---- | --3K |
Operating profit before the change of operating capital | ---- | -127.97%-3.16M | ---- | -8.93%11.28M | ---- | -18.36%12.39M | ---- | 27.37%15.17M | ---- | -64.42%11.91M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 556.69%9.86M | ---- | 59.94%-2.16M | ---- | -284.65%-5.39M | ---- | -24.42%-1.4M | ---- | 62.47%-1.13M |
Accounts receivable (increase)decrease | ---- | 274.80%9.4M | ---- | 35.38%-5.38M | ---- | -571.29%-8.32M | ---- | -90.21%1.77M | ---- | 183.23%18.05M |
Accounts payable increase (decrease) | ---- | 63.04%-3.43M | ---- | -197.03%-9.27M | ---- | 520.64%9.56M | ---- | 77.65%-2.27M | ---- | -150.17%-10.17M |
prepayments (increase)decrease | ---- | -157.70%-1.25M | ---- | 185.91%2.17M | ---- | -145.24%-2.53M | ---- | -1,420.51%-1.03M | ---- | 269.57%78K |
Cash from business operations | ---- | 440.19%11.43M | ---- | -158.87%-3.36M | ---- | -53.36%5.71M | ---- | -34.73%12.24M | ---- | -35.39%18.75M |
Other taxs | ---- | -28.43%-1.41M | ---- | -375.65%-1.09M | ---- | 93.15%-230K | ---- | 46.06%-3.36M | ---- | -102.21%-6.22M |
Special items of business | 167.31%8.32M | ---- | 246.47%3.11M | ---- | 77.18%-2.13M | ---- | -212.16%-9.32M | ---- | -26.11%-2.99M | ---- |
Net cash from operations | 167.31%8.32M | 325.06%10.02M | 246.47%3.11M | -181.32%-4.45M | 77.18%-2.13M | -38.32%5.48M | -212.16%-9.32M | -29.10%8.88M | -26.11%-2.99M | -51.72%12.52M |
Cash flow from investment activities | ||||||||||
Interest received - investment | 345.00%89K | 104.00%51K | 233.33%20K | -69.51%25K | -76.92%6K | 34.43%82K | 4.00%26K | -16.44%61K | -60.32%25K | 65.91%73K |
Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---8.59M | ---- | ---- | ---- | ---- |
Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | -60.11%215K | ---- | --539K | ---- | ---- |
Purchase of fixed assets | 65.66%-125K | -12.55%-583K | 19.65%-364K | -3.60%-518K | -906.67%-453K | 56.90%-500K | -275.00%-45K | -146.28%-1.16M | 69.23%-12K | -823.53%-471K |
Purchase of intangible assets | ---- | ---- | ---- | ---8.3M | ---8.3M | ---- | ---- | ---- | ---- | ---- |
Sale of subsidiaries | --58K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash on investment | ---- | ---- | ---- | ---- | ---- | ---13M | ---- | ---- | ---- | ---- |
Net cash from investment operations | 106.40%22K | 93.95%-532K | 96.07%-344K | 59.66%-8.79M | -45,926.32%-8.75M | -3,791.25%-21.79M | -246.15%-19K | -40.70%-560K | -45.83%13K | -5,585.71%-398K |
Net cash before financing | 201.30%8.35M | 171.66%9.49M | 125.48%2.77M | 18.82%-13.24M | -16.43%-10.87M | -296.14%-16.32M | -214.17%-9.34M | -31.39%8.32M | -26.85%-2.97M | -53.24%12.12M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | --540K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Refund | 0.00%-2.05M | 0.00%-4.1M | 0.00%-2.05M | -5.30%-4.1M | -4.22%-2.05M | 12.01%-3.89M | 11.13%-1.97M | 0.00%-4.42M | 0.00%-2.21M | 0.00%-4.42M |
Issuing shares | ---- | ---- | ---- | ---- | ---- | --28.5M | --28.5M | ---- | ---- | ---- |
Interest paid - financing | 19.92%-406K | -46.06%-1.04M | -115.74%-507K | -91.37%-710K | -23.04%-235K | 36.25%-371K | 46.05%-191K | 49.35%-582K | 40.90%-354K | -6.09%-1.15M |
Dividends paid - financing | ---- | -239.98%-17.86M | -239.98%-17.86M | 23.07%-5.25M | 23.07%-5.25M | 24.13%-6.83M | 24.13%-6.83M | 25.00%-9M | 25.00%-9M | -50.00%-12M |
Absorb investment income | ---- | ---- | ---- | -6.53%830K | -6.53%830K | --888K | --888K | ---- | ---- | ---- |
Other items of the financing business | ---- | ---- | ---- | --1.57M | --648K | ---- | ---- | --3.45M | ---- | ---- |
Net cash from financing operations | 86.97%-2.69M | -192.23%-23M | -240.81%-20.65M | -143.02%-7.87M | -129.69%-6.06M | 271.77%18.3M | 275.44%20.4M | 39.80%-10.65M | 21.80%-11.63M | -31.04%-17.7M |
Effect of rate | 88.09%-48K | 78.38%-104K | 59.04%-403K | -234.36%-481K | -1,689.09%-984K | 293.41%358K | -2,650.00%-55K | 171.09%91K | 97.53%-2K | 48.80%-128K |
Net Cash | 131.64%5.66M | 36.00%-13.51M | -5.59%-17.88M | -1,164.31%-21.12M | -252.97%-16.93M | 184.97%1.98M | 175.79%11.07M | 58.09%-2.34M | 15.18%-14.6M | -144.85%-5.57M |
Begining period cash | -27.55%35.82M | -30.40%49.44M | -30.40%49.44M | 3.41%71.03M | 3.41%71.03M | -3.16%68.69M | -3.16%68.69M | -7.44%70.94M | -7.44%70.94M | 18.88%76.64M |
Cash at the end | 32.96%41.43M | -27.55%35.82M | -41.35%31.16M | -30.40%49.44M | -33.35%53.12M | 3.41%71.03M | 41.49%79.7M | -3.16%68.69M | -5.07%56.33M | -7.44%70.94M |
Cash balance analysis | ||||||||||
Cash and bank balance | ---- | ---- | ---- | ---- | ---- | --71.03M | ---- | ---- | ---- | -7.44%70.94M |
Cash and cash equivalent balance | ---- | ---- | ---- | ---- | ---- | --71.03M | ---- | ---- | ---- | -7.44%70.94M |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.